NEP Stats & Data

Why this matters and how to reduce risk: 1) Human in‑vivo pharmacokinetics are unknown; an in‑vitro study in human liver microsomes found a long metabolic half‑life (~770 min ≈ 12.8 h), so redosing can stack and prolong sympathomimetic strain even if the subjective ‘rush’ fades. Space doses and avoid consecutive‑day use. 2) Mislabeling is common: multiple Swiss drug‑checking alerts found NEP sold as 3‑MMC; because NEP is active at much lower oral doses (≈20–50 mg vs 100–200 mg for 3‑MMC), substitution markedly increases overdose risk. Use accredited drug‑checking when possible; if not, start with a very small test dose and wait fully for effects. 3) Cardiovascular and hyperthermia risks are central with cathinones; clinical cases with NEP have included severe agitation, fever, rhabdomyolysis and acute kidney injury. Avoid hot environments and intense exertion; take cooling breaks; sip isotonic fluids (not excessive water) and replace electrolytes during prolonged activity. 4) Seizure risk is heightened by co‑factors (sleep deprivation, dehydration, tramadol, bupropion, stimulant stacking). Avoid these combinations and ensure sleep/nutrition before and after sessions. 5) Intranasal dosing produces a steeper rise, more peripheral side effects and greater compulsion than oral; vaporizing/inhalation reports often describe very short cycles with strong urges to redose and respiratory irritation—prefer oral if you choose to use at all. 6) Set maximum session amounts in advance, measure doses with a 0.001 g scale, and avoid ‘chasing’ diminishing returns—compulsion is a common pathway to harm. 7) Because NEP is frequently mis‑sold, reagents may not reliably distinguish it from other cathinones; lab drug‑checking (FTIR/GC‑MS/LC‑HRMS) is the safest way to identify contents. 8) Aftercare: expect a dysphoric ‘crash’; plan nutrition, hydration and sleep; consider a non‑sedating day off stimulants for at least 14+ days to let tolerance and cardiovascular strain normalize. 9) Seek urgent care for red‑flag symptoms: persistent chest pain, severe headache, confusion/delirium, temperature >38.5°C (101.3°F), rigid muscles, dark urine, or inability to keep fluids down.